Investor Relations

Harris & Harris Group, Inc.® is an internally managed investment company. We have elected to be regulated as a business development company ("BDC") under the Investment Company Act of 1940, (the "1940 Act"). For tax purposes, we have elected to be treated as a regulated investment company ("RIC") under Subchapter M of the Internal Revenue Code of 1986 (the "Code"). We were incorporated under the laws of the state of New York in August 1981. We are overseen by our Board of Directors and managed by our officers and have no external investment advisor.
 
Harris & Harris Group builds transformative companies enabled by disruptive science by identifying and investing in such companies and then providing strategic, operational and management resources, and creative financial solutions.

View all »   RSSRecent Releases

09/20/16
Article on Nextbigfuture.com Highlights D-Wave Systems Next Quantum Chip

09/19/16
CB Insights Analyzes the Quantum Computing Space and Highlights D-Wave

08/15/16
Harris & Harris Group to Host a Shareholder Update Call, Including a Presentation by One of Its Precision Health and Medicine Portfolio Companies, Muses Labs, Inc., on August 23, 2016

08/11/16
Harris & Harris Group Portfolio Company, Metabolon, Inc., Closes $15 Million Financing to Support Precision Medicine Growth Opportunities

NASDAQTINY
Price:$1.38
Change-0.72% 0.01
Day High$1.40
Day Low$1.35
Volume95,143

As of 3:58 PM ET on 09/26/16
Quote delayed at least 20 minutes.

More

Corporate Headquarters
1450 Broadway, 24th Floor
New York, NY 10018
Phone: 212 582 0900
Fax: 212 582 9563
admin@hhvc.com

West Coast Office:
530 Lytton Avenue - 2nd Floor
Palo Alto, CA 94301
Phone: 650 617 3386
Fax: 650 617 3201